CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- 4 Open-market sale Chief Patient Supply Officer sold 4,846 shares at an average $3.55 ($17,222)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 4,624 shares at an average $3.55 ($16,435)
- 4 Open-market sale Chief Executive Officer sold 17,408 shares at an average $3.55 ($61,877)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Operating Officer sold 3,490 shares at $4.06 ($14,184)
- 4 Open-market sale Chief Patient Supply Officer sold 1,070 shares at $4.06 ($4,349)
- 4 Open-market sale Chief Medical Officer sold 849 shares at $4.06 ($3,451)
- 4 Open-market sale Chief Executive Officer sold 5,532 shares at $4.06 ($22,483)
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Material agreement · Regulation FD disclosure · Other events
- 4 Open-market sale Chief Executive Officer sold 2,782 shares at $5.20 ($14,452)
- 8-K Event Material agreement
- 8-K Event Material agreement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 15 of 41 · 808 filings